Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study

Sabine Käyser(German Cancer Research Center), Mark J. Levis(Sidney Kimmel Cancer Center), Michael Krämer(University Hospital Carl Gustav Carus), Andrew M. Brunner(Harvard University), Petr Cetkovský(Charles University), David Martínez‐Cuadrón(Instituto de Salud Carlos III), Marlise R. Luskin(Dana-Farber Cancer Institute), Christoph Röllig(University Hospital Carl Gustav Carus), Klaus H. Metzeler(University Hospital Leipzig), Sandra Casal Marini(Hospitais da Universidade de Coimbra), Cristina Gil(Hospital General Universitario de Alicante Doctor Balmis), Pau Montesinos(Instituto de Salud Carlos III), Alexander E. Perl(University of Pennsylvania), Friedrich Stölzel(German Cancer Research Center), Richard F. Schlenk(German Cancer Research Center), Zuzana Šustková(Masaryk University), Michelle A. Elliott(Mayo Clinic), Jan Novák(Institute of Haematology and Blood Transfusion), Anthony D. Ho(Heidelberg University), Richard M. Stone(Dana-Farber Cancer Institute), Uwe Platzbecker(National Center for Tumor Diseases), Justin Grenet(Cornell University), Zdeněk Ráčil(Masaryk University), Christian Thiede(University Hospital Carl Gustav Carus)
Haematologica
August 5, 2021
Cited by 34


Related Papers